BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2535561)

  • 1. [Absence of delta agent infection in high risk male subjects infected with B virus and human immunodeficiency virus].
    Deibis L; Márquez M; Bianco NE; Pérez GE; Machado IV
    G E N; 1989; 43(3):202-4. PubMed ID: 2535561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study.
    Amini S; Mahmoodi MF; Andalibi S; Solati AA
    J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to hepatitis delta virus in intravenous drug addicts and male homosexuals in Spain.
    León P; López JA; Contreras G; Echevarría JM
    Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):533-5. PubMed ID: 3141166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology of hepatitis D virus infection].
    Joller-Jemelka HI; Guggi T; Grob PJ
    Schweiz Med Wochenschr; 1985 Nov; 115(47):1679-84. PubMed ID: 4081699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Infection caused by the human immunodeficiency virus, hepatitis B virus and delta virus in homosexual males].
    Bassa A; Villalonga C; Parras F; Salvà F; Altés J; Salas A
    Med Clin (Barc); 1989 Oct; 93(13):490-2. PubMed ID: 2622241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retrospective (1970-1984) serological study of delta antigen and antibody. Observations on seroconversion and absence of delta in non-A, non-B hepatitis].
    Stroun J; Peitrequin R; Frei PC
    Schweiz Med Wochenschr; 1987 Feb; 117(9):307-14. PubMed ID: 3105053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological study of fulminant hepatitis: coinfection with hepatitis B virus and delta agent.
    Krajden S; Bishai F; Huang SN; Ronald A; Harris F; Kempston J; Anderson J; Keston S
    CMAJ; 1986 Dec; 135(11):1282-5. PubMed ID: 3536053
    [No Abstract]   [Full Text] [Related]  

  • 8. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
    Shirin T; Ahmed T; Iqbal A; Islam M; Islam MN
    J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delta hepatitis in Malaysia.
    Sinniah M; Dimitrakakis M; Tan DS
    Southeast Asian J Trop Med Public Health; 1986 Jun; 17(2):229-33. PubMed ID: 3787309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B virus (HBV) and dual HBV-hepatitis delta virus (HDV) infection in apparently healthy persons.
    Brehar-Cioflec D; Claici C; Roşiu N; Negrea DA; Moldovan R; Coşniţă M
    Rom J Virol; 1998; 49(1-4):3-10. PubMed ID: 10892421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
    Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
    Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDV infection in Cyprus.
    Eleftheriou A; Teloni F; Ioannou P
    Prog Clin Biol Res; 1993; 382():277-85. PubMed ID: 8502692
    [No Abstract]   [Full Text] [Related]  

  • 14. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
    Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
    J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study).
    Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S
    J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of human immunodeficiency virus and its association with hepatitis B, C, and D virus infections among incarcerated male substance abusers in Taiwan.
    Chu FY; Chiang SC; Su FH; Chang YY; Cheng SH
    J Med Virol; 2009 Jun; 81(6):973-8. PubMed ID: 19382252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of delta virus infection in Thai intravenous drug abusers.
    Louisirirotchanakul S; Wasi C; Uneklabh C; Phutiprawan T; Suwanagool S; Chainuvati T; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1988 Jun; 19(2):191-5. PubMed ID: 3227398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
    Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
    Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and epidemiological significance of hepatitis delta virus (HDV) infection in chronic HBV carriers in Portugal.
    Ramalho F; Carvalho G; Bonino F; Baptista A; de Moura MC
    Prog Clin Biol Res; 1987; 234():409-17. PubMed ID: 3628400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-hepatitis delta virus seroprevalence and risk factors in patients with hepatitis B in Southeast Turkey.
    Celen MK; Ayaz C; Hosoglu S; Geyik MF; Ulug M
    Saudi Med J; 2006 May; 27(5):617-20. PubMed ID: 16680248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.